COLUMBUS, Ohio — Cleveland-based AIM Pharmakon and Cincinnati’s AssureRx this week both received economic development incentives from the state of Ohio.
AssureRx, which is developing a genetic test for psychiatric medicines, will receive a $1.2 million low-interest loan from the state to help with $1.6 million in costs for new computer and laboratory equipment, intellectual property acquisition and protection, as well as other expenses, according to a press release from the state’s Department of Development.
The loan will have a 1 percent interest rate in its first year and a 6 percent rate for the final six years. The project is expected to create 30 jobs and help retain seven others.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
AssureRx is also expected to close a Series A round of private financing by year’s end.
AIM, meanwhile, received a seven-year job-creation tax credit worth about $205,589, according to the state’s Department of Development. The company, which provides marketing and consulting services for the pharmaceutical industry, is embarking on a $1 million project in its new facility in Cleveland and is expected to create 40 jobs. The company will be required to remain at the location for 14 years.
